Guardant Health

173 articles with Guardant Health

• Guardant Health And Labco Quality Diagnostics (synlab Group) Announce Joint International Expansion

  12/2/2015

• Guardant Health And Collaborators Present Further Clinical Utility Data For Guardant360 At The AACR-National Cancer Institute-EORTC International Conference On Molecular Targets And Cancer Therapeutics

  11/9/2015

• Guardant Health Release: New Studies Show The Power Of Comprehensive, Non-Invasive Solid-Tumor Genomic Testing With Guardant360

  10/20/2015

• Guardant Health Partners With National Cancer Institute On First Ever Prospective Study To Implement cfDNA Genomic Profiling For Non-Small Cell Lung Cancer

  6/24/2015

• Guardant Health Release: Leading Cancer Centers To Present Clinical Utility Data For Guardant360 At ASCO

  5/27/2015

• Guardant Health Results Of Decision Impact Study Of Guardant360 In Metastatic Colorectal Cancer To Be Presented At AACR

  4/21/2015

• Guardant Health Presents Data On Biopsy-Free Tumor Genomic Profiling Of More Than 2000 Clinical Samples Via Guardant360

  4/20/2015

• Guardant Health And Academic Collaborators To Present Clinical Utility Of Guardant360 For Solid Tumor Cancers

  4/8/2015

• Guardant Health Banks $50 Million for Liquid Biopsy Cancer Test

  2/3/2015

• Guardant Health To Present At The Wedbush 2014 Life Sciences Management Access Conference

  8/8/2014

• N-Of-One Selected By Guardant Health To Provide Clinical Interpretation For Guardant360™ Tests

  5/19/2014

• Redwood City Diagnostic Company Guardant Health Reels In $30 Million Series B

  4/22/2014

• Guardant Health Releases Breakthrough Blood Test To Improve Cancer Treatment

  2/13/2014